Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons; Daniel Rayson; Anil Abraham Joy; Jan Willem Henning; Julie Lemieux; Heather McArthur; Paul B. Card; Rebecca Dent; Christine Brezden-Masley

doi:10.1177/17588359211066677

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons, Daniel Rayson, Anil Abraham Joy, Jan Willem Henning, Julie Lemieux, Heather McArthur, Paul B. Card, Rebecca Dent, Christine Brezden-Masley

Computer Science

科研成果: 期刊稿件 › 文献综述 › 同行评审

24 引用（Scopus）

源语言	英语
期刊	Therapeutic Advances in Medical Oncology
卷	14
DOI	https://doi.org/10.1177/17588359211066677
出版状态	已出版 - 1月 2022

!!!ASJC Scopus Subject Areas

肿瘤学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1177/17588359211066677

其它文件与链接

引用此

@article{6ce2f3641f1f4d14a7c0114c82c4ed8b,

title = "Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines",

keywords = "HER2-positive, T-DM1, T-DXd, advanced disease, breast cancer, neratinib, pertuzumab, trastuzumab, tucatinib",

author = "Christine Simmons and Daniel Rayson and Joy, {Anil Abraham} and Henning, {Jan Willem} and Julie Lemieux and Heather McArthur and Card, {Paul B.} and Rebecca Dent and Christine Brezden-Masley",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2022.",

year = "2022",

month = jan,

doi = "10.1177/17588359211066677",

language = "English",

volume = "14",

journal = "Therapeutic Advances in Medical Oncology",

issn = "1758-8340",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Current and future landscape of targeted therapy in HER2-positive advanced breast cancer

T2 - redrawing the lines

AU - Simmons, Christine

AU - Rayson, Daniel

AU - Joy, Anil Abraham

AU - Henning, Jan Willem

AU - Lemieux, Julie

AU - McArthur, Heather

AU - Card, Paul B.

AU - Dent, Rebecca

AU - Brezden-Masley, Christine

N1 - Publisher Copyright: © The Author(s), 2022.

PY - 2022/1

Y1 - 2022/1

KW - HER2-positive

KW - T-DM1

KW - T-DXd

KW - advanced disease

KW - breast cancer

KW - neratinib

KW - pertuzumab

KW - trastuzumab

KW - tucatinib

UR - http://www.scopus.com/inward/record.url?scp=85122959114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122959114&partnerID=8YFLogxK

U2 - 10.1177/17588359211066677

DO - 10.1177/17588359211066677

M3 - Review article

AN - SCOPUS:85122959114

SN - 1758-8340

VL - 14

JO - Therapeutic Advances in Medical Oncology

JF - Therapeutic Advances in Medical Oncology

ER -

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此